Navigation Links
Volcano Reports 35 Percent Increase in Third Quarter Revenues; Records $9.6 Million Improvement in Year-Over-Year GAAP Profitability
Date:11/3/2010

SAN DIEGO, Nov. 3, 2010 /PRNewswire-FirstCall/ -- Volcano Corporation (Nasdaq: VOLC), a leading developer and manufacturer of precision intravascular diagnosis and therapy guidance tools designed to enhance the treatment of coronary and peripheral vascular disease, said today that revenues in the third quarter of 2010 increased 35 percent over revenues in the same period a year ago. The company's profitability on a GAAP basis improved $9.6 million year-over-year as it reported net income of $5.6 million in the third quarter of 2010.

For the quarter ended September 30, 2010, Volcano reported revenues of $72.9 million, compared to revenues of $53.9 million in the third quarter of fiscal 2009. The company reported net income on a GAAP basis of $5.6 million, or $0.10 per diluted share, in the third quarter of 2010, versus a GAAP net loss of $4.0 million, or $0.08 per share, in the third quarter of 2009.

Excluding stock-based compensation of $3.0 million, the company reported net income of $8.6 million, or $0.16 per diluted share, in the third quarter of 2010. Excluding stock-based compensation expense of $2.6 million and $1.4 million in commissions to a former distributor, the company reported net income of $7,000, or $0.00 per diluted share, in the third quarter of 2009.

For the first nine months of 2010, Volcano reported revenues of $212.9 million, a 36 percent increase over revenues of $156.9 million in the same period a year ago. The company reported GAAP net income of $7.0 million, or $0.13 per diluted share, in the first nine months of 2010. This compares with a GAAP net loss of $16.9 million, or $0.35 per share, in the same period of 2009. Excluding stock-based compensation expense of $9.2 million, Volcano reported net income of $16.3 million, or $0.31 per diluted share, in the first nine months of 2010. In the first nine months of 2009, excluding stock-based
'/>"/>

SOURCE Volcano Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Volcano Drives Innovation Forward With Three New U.S. Product Launches at TCT 2010
2. Volcano Announces It Will End Distribution Agreement with Fukuda; Transition Enhances Companys Direct Selling Program in Japan
3. Volcano Corporation Files Counterclaim Asserting St. Jude Infringes Three Volcano Patents; Answers St. Judes Patent Infringement Claims
4. Volcano Corporation Prices $100 Million 2.875 Percent Convertible Senior Notes Due 2015
5. Volcano Corporation to Offer $100 Million Convertible Senior Notes Due 2015
6. Volcano Corporation Presentation at Canaccord Genuity Growth Conference to be Webcast
7. Volcano Will Strongly Defend Against St. Jude Lawsuit
8. Volcano Announces Plans to Introduce Multiple New Products at EuroPCR 2010
9. Physicians Cite Positive First Clinical Experience with Volcanos Eagle Eye® Platinum Digital IVUS Catheter
10. Volcano Corporation Presentation at Bank of America Merrill Lynch Health Care Conference to Be Webcast
11. Volcano Announces Distribution Agreement With AngioScore for the AngioSculpt(R) PTCA Scoring Balloon Catheter in Japan
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/24/2014)... 2014   Synageva BioPharma Corp. (NASDAQ: ... therapeutic products for rare disorders, today announced validation ... Marketing Authorization Application (MAA) for sebelipase alfa for ... request for accelerated assessment, which has the potential ... The MAA, and the Biologics License ...
(Date:12/24/2014)... China , Dec. 23, 2014 ... pharmaceutical company that specializes in patented biopharmaceutical, modernized ... pharmaceutical ingredients (API) today announced that the Company ... its Good Manufacturing Practice (GMP) certificate of TPI,s ... Drug Administration,s (CFDA). The public notice period is ...
(Date:12/22/2014)... , Dec. 22, 2014  CytoSorbents Corporation (OTCQB:CTSOD), ... CytoSorb® blood purification technology to help fight deadly ... 28 countries worldwide, today announced the appointment of ... FACS, as its Senior Vice President of Clinical ... Dr. Di Russo is an accomplished ...
Breaking Medicine Technology:Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 2Synageva BioPharma Announces Sebelipase Alfa Marketing Authorization Application Validated By The EMA 3TPI QLF Achieved Public Notice Status of GMP Certification 2TPI QLF Achieved Public Notice Status of GMP Certification 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 2CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 3CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 4CytoSorbents Appoints Dr. Gregory B. Di Russo as Senior Vice President of Clinical Development 5
(Date:12/24/2014)... December 24, 2014 Connie Casad, MD, ... functional medicine advocate with 30 years of practice experience ... evaluate the health benefits of dietary detoxification. The second ... participants following excellent results from test patients who just ... to explain her interest in conducting the study, Dr. ...
(Date:12/24/2014)... (PRWEB) December 24, 2014 Risperdal lawsuit ... a mass tort litigation currently underway in Pennsylvania’s Philadelphia ... As of December 24, 2014, court documents indicate that ... behalf of individuals who developed gynecomastia (male breast growth) ... from the Court indicates that this represents an increase ...
(Date:12/24/2014)... Dr. Vu Ho, a Dallas based facial plastic ... med-spa with the addition of new Silk Peel skin ... and services. , “Silk Peel is a procedure that ... “As a result it can address issues like acne ... or blemishes.” , Similar to microdermabrasion, Silk Peel ...
(Date:12/24/2014)... Today, UWDress.com, the famous women’s dress supplier, ... and launched a site-wide wedding gown promotion. , ... in a more unexpected way, the collection should be a ... the global market, and they are available with custom service. ... at discounted prices, up to 75% off; most of them ...
(Date:12/24/2014)... The report “Stivarga (Colorectal Cancer) – Forecast ... treatment landscape, unmet needs, current pipeline and commercial opportunities ... which is used in the treatment of colon or ... also prescribed to patients who suffer from advanced gastrointestinal ... a multi-kinase inhibitor and it blocks many enzymes which ...
Breaking Medicine News(10 mins):Health News:Connie Casad, MD, Now Accepting Test Participants for January Dietary Detoxification Study 2Health News:Connie Casad, MD, Now Accepting Test Participants for January Dietary Detoxification Study 3Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 2Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 3Health News:Risperdal Lawsuits Continue to Climb, as Claims in Pennsylvania Litigation Exceed 1,180 Filings, Bernstein Liebhard LLP Reports 4Health News:Dr. Vu Ho Expands Facial Plastic Surgery Practice to Include New Skin Care Treatment 2Health News:Buy Cheap Long Sleeve Wedding Gowns At UWDress.com 2Health News:Stivarga Colorectal Cancer Treatment Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 2Health News:Stivarga Colorectal Cancer Treatment Market Analysis and Forecast to 2023 Report at RnRMarketReserach.com 3
... WASHINGTON, D.C.Exemplary work in genetic imaging and therapy have ... & Molecular Biology at Jefferson Medical College of Thomas ... at Jefferson, recognition by his peers as a 2010 ... Science (AAAS). AAAS is honoring Dr. Wickstrom for ...
... HealthDay Reporter , TUESDAY, Jan. 11 (HealthDay News) ... attitude: The most optimistic adolescents may be somewhat less likely ... have found a slight link between optimism and less heavy ... new research, on kids in Australia, doesn,t prove that optimism ...
... a common problem for patients with schizophrenia. The increased tendency ... smoke, but to do so more heavily than the general ... acting as a treatment for some symptoms of schizophrenia. ... those with high and low affinity for nicotine. The low ...
... remains an unresolved issue as to whether interstitial brachytherapy has ... prostate cancer, nor do newer studies provide proof in this ... the Institute for Quality and Efficiency in Health Care (IQWiG) ... newer studies challenged the findings of research already completed in ...
... risk of an ectopic pregnancy because of a lasting effect ... the first time of how chlamydia can increase the risk ... implants outside the womb, in the Fallopian tube. Researchers ... had the sexually transmitted infection were more likely to produce ...
... HealthDay Reporter , TUESDAY, Jan. 11 (HealthDay News) -- The ... on Saturday will likely cause some permanent damage, but experts ... be. However, doctors at University Medical Center in Tucson ... are already encouraged by her ability to follow simple instructions. ...
Cached Medicine News:Health News:Optimism Could Help Kids Keep Depression at Bay 2Health News:Targeting nicotine receptors to treat cognitive impairments in schizophrenia 2Health News:Benefit of brachytherapy in patients with early-stage prostate cancer is still unclear 2Health News:Benefit of brachytherapy in patients with early-stage prostate cancer is still unclear 3Health News:Benefit of brachytherapy in patients with early-stage prostate cancer is still unclear 4Health News:Wounded Congresswoman Responds to Simple Commands 2Health News:Wounded Congresswoman Responds to Simple Commands 3Health News:Wounded Congresswoman Responds to Simple Commands 4
... SYSCAN3® Hospital Test Kit is a multi-well ELISA ... in a standard serology laboratory without the need ... specific antigen preparation from Candida albicans. Our SYSCAN3 ... the presence of antibodies to Candida in the ...
Immunodiffusion tests are used for the detecion of precipitating antibodies (primarily of the IgG and IgA classes) against antigens of C. albicans. The presence of precipitating antibodies indicates ...
... Health Record streamlines patient information management ... A flexible and easily customizable solution, ... financial benefits. HealthMatics EHR organizes communication ... and with outside practitioners. It also ...
... generation of advanced Electronic Medical Records (EMR) ... numerically codified medical vocabularies in the world. ... embedded in MedcomSoft Record, healthcare providers can ... and intuitive point and click system and ...
Medicine Products: